PT-141 (bremelanotide) is a peptide that engages melanocortin receptors in the central nervous system — a pathway involved in the body's natural arousal signaling. Unlike approaches that work locally, it acts upstream, at the level of neural signaling that shapes desire. It is studied for its role in supporting sexual response in women, particularly when low desire appears to originate in signaling rather than in physical mechanics alone.
Desire functions as a signal, and like other signals, it can go quiet under stress, fatigue, or hormonal change. PT-141 isn't designed to manufacture arousal — it's studied for its role in supporting the signaling pathway the body already uses to generate it.
What it's used to support.
- May support the melanocortin signaling pathway involved in the body's natural arousal response.
- Is being explored for its role in low sexual desire connected to neural signaling rather than blood flow alone.
- Works systemically, through the central nervous system, rather than through a local or topical effect.
- Typically considered as part of a broader hormonal and metabolic picture, not as a standalone fix.
- Introduced and monitored by a licensed practitioner as part of an individualized protocol.
Most relevant for women 35 and older navigating a drop in desire tied to hormonal transition, chronic stress, or midlife metabolic change — especially when the concern sits more in wanting than in physical response. It's considered within the context of a full hormonal picture, established with a licensed practitioner, not used in isolation.
This compound's format and dosing are pending clinical validation and are not published generically — they are confirmed one-to-one with a licensed practitioner based on your history and goals.
Before you start.
Administration route and protocol are individualized. Exact dosing is pending clinical validation and is confirmed with a licensed practitioner during consultation, based on your health history and goals.
Response time varies by individual and by the protocol your practitioner designs. We don't attach a fixed timeline to any protocol — your practitioner will walk you through realistic expectations for your specific plan.
PT-141 should only be introduced under the guidance of a licensed practitioner, who can review your health history, current medications, and goals to determine whether it's an appropriate fit.
Every Inner Peptides formula is independently tested before it ships, with a Certificate of Analysis available on request. Learn more about our testing standard.